James E. Krause

Nessuna posizione attualmente

72 anni

Health Technology

Consumer Services

Precedenti posizioni note di James E. Krause

Società	Posizione	Inizio	Fine
Washington University in St. Louis	Corporate Officer/Principal	01/01/1997	01/01/1997
ARMGO Pharma, Inc. ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY.	Direttore Tecnico/Scientifico/R&S	05/11/2009	-
Neurogen Corp. Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT.	Corporate Officer/Principal	01/01/1997	-

University of Wisconsin

Doctorate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	2
Doctorate Degree	1
Undergraduate Degree	1

Settori

Health Technology	3
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	2
Neurogen Corp. Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT.	Health Technology
ARMGO Pharma, Inc. ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY.	Health Technology

Aziende private

Health Technology